Severe COVID-19 in inflammatory bowel disease patients in a population-based setting. by Rob H Creemers, Ashkan Rezazadeh Ardabili, Daisy M Jonkers, Mathie P G Leers, Mariëlle J Romberg-Camps, Marie J Pierik, Ad A van Bodegraven

Get full text

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency by Debbie S. Deben, Luc J. J. Derijks, Bianca J. C. van den Bosch, Rob H. Creemers, Annick van Nunen, Adriaan A. van Bodegraven, Dennis R. Wong

Get full text

A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patients by Debbie S. Deben, Rob H. Creemers, Arjan J. van Adrichem, Roosmarie Drent, Audrey H. H. Merry, Mathie P. G. Leers, Adriaan A. van Bodegraven, Dennis R. Wong

Get full text

Cohort Profile: The Christchurch IBS cOhort to investigate Mechanisms FOr gut Relief and improved Transit (COMFORT) by Phoebe Heenan, Rob H. Creemers, Shriya Sharma, Jacqueline Keenan, Simone Bayer, Wayne Young, Janine Cooney, Kelly Armstrong, Karl Fraser, Paula M. Skidmore, Nicholas J. Talley, Nicole Roy, Richard B. Gearry

Get full text

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY Study by Merve Sivridaş, Rob H. Creemers, Dennis R. Wong, Paul J. Boekema, Tessa E. H. Römkens, Lennard P. L. Gilissen, Adriaan A. van Bodegraven, Floris C. Loeff, Theo Rispens, Luc J. J. Derijks

Get full text